Gx Acquisiton Corp Cl A (GXGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GXGX | AMGN | VRTX | BMY | GILD |
| Company | Gx Acquisiton Corp Cl A | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 8.18 | 297.91 | 495.62 | 58.91 | 92.31 |
| High | 12.58 | 298.48 | 496.33 | 59.73 | 92.66 |
| Low | 8.07 | 292.33 | 483.55 | 58.26 | 91.29 |
| Last | 10.20 | 295.93 | 483.96 | 58.50 | 92.11 |
| Change | +2.18 | -5.51 | -10.65 | +0.09 | -0.52 |
| % Change | +27.18% | -1.83% | -2.15% | +0.15% | -0.56% |
| Volume | 17,319,200 | 3,515,600 | 1,231,500 | 11,494,200 | 8,202,700 |
| 20-Day Average Volume | 1,188,490 | 2,323,920 | 1,180,065 | 10,839,435 | 6,971,395 |
| Previous Close | 8.02 | 301.44 | 494.61 | 58.41 | 92.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.00 | 315.85 | 484.02 | 54.76 | 90.60 |
| 20-Day Raw Stochastic | 50.93% | 10.03% | 36.69% | 72.17% | 48.95% |
| 20-Day Relative Strength | 52.40% | 33.68% | 50.71% | 64.34% | 59.95% |
| Weighted Alpha | -0.69 | +5.13 | +31.67 | +25.12 | +31.11 |
| Today's Opinion | 56% Sell | 40% Sell | 72% Buy | 100% Buy | 96% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 8% Sell | 40% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.10% since 07/09/21 | -8.07% since 11/07/24 | -3.68% since 11/07/24 | +6.93% since 11/07/24 | -5.91% since 11/07/24 |
| Low | 7.73 on 07/15/21 | 292.33 on 11/14/24 | 483.55 on 11/14/24 | 53.97 on 11/08/24 | 91.29 on 11/14/24 |
| High | 12.58 on 07/16/21 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | +0.29% since 06/16/21 | -8.84% since 10/14/24 | -0.18% since 10/14/24 | +11.07% since 10/14/24 | +8.30% since 10/14/24 |
| Low | 7.73 on 07/15/21 | 292.33 on 11/14/24 | 463.14 on 11/01/24 | 51.31 on 10/15/24 | 84.80 on 10/15/24 |
| High | 12.58 on 07/16/21 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +0.99% since 04/16/21 | -8.30% since 08/14/24 | +2.66% since 08/14/24 | +20.84% since 08/14/24 | +24.24% since 08/14/24 |
| Low | 7.73 on 07/15/21 | 292.33 on 11/14/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 12.58 on 07/16/21 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -2.86% since 01/15/21 | -4.97% since 05/14/24 | +12.92% since 05/14/24 | +30.84% since 05/14/24 | +36.16% since 05/14/24 |
| Low | 7.73 on 07/15/21 | 292.33 on 11/14/24 | 428.62 on 05/15/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 12.58 on 07/16/21 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 366,557 | 162,033,952 | 127,376,408 | 118,465,824 | 115,323,600 |
| Shares Outstanding, K | 35,937 | 537,533 | 257,529 | 2,028,177 | 1,244,992 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -2,630,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | 38,028,962 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.17 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | N/A | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.55 | 0.00 | 50.44 | 21.30 |